Literature DB >> 24415580

Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Jordi Miró1, Kevin J Gertz, Gregory T Carter, Mark P Jensen.   

Abstract

INTRODUCTION: We examined the effects of pain site and intensity on function in patients with myotonic dystrophy type 1 (DM1) and facioscapulohumeral muscular dystrophy (FSHD) and chronic pain.
METHODS: Questionnaires assessing pain sites, pain extent (number of sites), pain intensity, and pain interference were completed by 182 individuals with DM1 (43%) or FSHD (57%) and chronic pain.
RESULTS: There was a positive association between pain extent and intensity with pain interference, and a negative association with psychological functioning in both DM1 and FSHD. Pain intensity at specific sites had differential impact beyond the effects of pain intensity alone. Head pain intensity independently affected psychological functioning, whereas leg, foot, hip, and knee pain contributed independently to the prediction of pain interference.
CONCLUSIONS: Pain site and intensity differentially modulates the effect of chronic pain on function in DM1 and FSHD patients. Researchers and clinicians should consider these factors when assessing and treating pain.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  facioscapulohumeral muscular dystrophy; myotonic dystrophy type 1; pain assessment; pain management; rehabilitation

Mesh:

Year:  2014        PMID: 24415580      PMCID: PMC5539515          DOI: 10.1002/mus.24079

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  41 in total

1.  Using generic measures of functional health and well-being to increase understanding of disease burden.

Authors:  J E Ware
Journal:  Spine (Phila Pa 1976)       Date:  2000-06-15       Impact factor: 3.468

2.  Comparative reliability and validity of chronic pain intensity measures.

Authors:  M P Jensen; J A Turner; J M Romano; L D Fisher
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

3.  Interpreting SF-36 summary health measures: a response.

Authors:  J E Ware; M Kosinski
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 4.  Chronic pain in persons with neuromuscular disease.

Authors:  Amy J Hoffman; Mark P Jensen; R Ted Abresch; Gregory T Carter
Journal:  Phys Med Rehabil Clin N Am       Date:  2005-11       Impact factor: 1.784

5.  Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports.

Authors:  K M Bushby; C Pollitt; M A Johnson; M T Rogers; P F Chinnery
Journal:  Neuromuscul Disord       Date:  1998-12       Impact factor: 4.296

6.  If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  James E Hilbert; John T Kissel; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Donald B Sanders; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Contemp Clin Trials       Date:  2011-11-26       Impact factor: 2.226

7.  Simple patterns behind complex spatial pain reporting? Assessing a classification of multisite pain reporting in the general population.

Authors:  Carsten Oliver Schmidt; Sebastian E Baumeister
Journal:  Pain       Date:  2007-06-13       Impact factor: 6.961

8.  Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.

Authors:  Joke S Kalkman; Machiel J Zwarts; Maartje L Schillings; Baziel G M van Engelen; Gijs Bleijenberg
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

9.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

10.  Pain in youths with neuromuscular disease.

Authors:  Joyce M Engel; Deborah Kartin; Gregory T Carter; Mark P Jensen; Kenneth M Jaffe
Journal:  Am J Hosp Palliat Care       Date:  2009 Oct-Nov       Impact factor: 2.500

View more
  16 in total

1.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

2.  What Determines Whether a Pain is Rated as Mild, Moderate, or Severe? The Importance of Pain Beliefs and Pain Interference.

Authors:  Mark P Jensen; Catarina Tomé-Pires; Rocío de la Vega; Santiago Galán; Ester Solé; Jordi Miró
Journal:  Clin J Pain       Date:  2017-05       Impact factor: 3.442

3.  Pain location and functioning in persons with spinal cord injury.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  PM R       Date:  2014-01-18       Impact factor: 2.298

Review 4.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

5.  The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.

Authors:  Sarah Youssof
Journal:  Muscle Nerve       Date:  2016-03-01       Impact factor: 3.217

6.  A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

Authors:  Mariëlle Wohlgemuth; Richard J Lemmers; Marianne Jonker; Elly van der Kooi; Corinne G Horlings; Baziel G van Engelen; Silvere M van der Maarel; George W Padberg; Nicol C Voermans
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910

7.  Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Authors:  Chad Heatwole; Nicholas Johnson; Rita Bode; Jeanne Dekdebrun; Nuran Dilek; James E Hilbert; Elizabeth Luebbe; William Martens; Michael P McDermott; Christine Quinn; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

8.  Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).

Authors:  Johanna Hamel; Nicholas Johnson; Rabi Tawil; William B Martens; Nuran Dilek; Michael P McDermott; Chad Heatwole
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

9.  Pain extent and function in youth with physical disabilities.

Authors:  Jordi Miró; Rocío de la Vega; Catarina Tomé-Pires; Elisabet Sánchez-Rodríguez; Elena Castarlenas; Mark P Jensen; Joyce M Engel
Journal:  J Pain Res       Date:  2017-01-05       Impact factor: 3.133

10.  Multidimensional aspects of pain in myotonic dystrophies.

Authors:  Marina Peric; Stojan Peric; Nada Rapajic; Valerija Dobricic; Dusanka Savic-Pavicevic; Ivana Nesic; Svetlana Radojicic; Ivana Novakovic; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  Acta Myol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.